Med Tech Sentinel Features: A Company Profile for Pressure BioSciences

Aug. 17, 2009 - PRLog -- A recent Med Tech Sentinel feature reports a company profile for Pressure BioSciences whose novel food safety process called Pressure Cycling Technology (PCT) samples preparation in the study of genomes and proteins. http://www.onemedplace.com/blog/archives/2814

Over the past year, Americans have been subjected to a number of food contamination scares. Contaminated beef, peanut butter, cookie dough, and more have sickened and even killed many in the U.S. Last week, the U.S. House passed a measure to overhaul food safety laws.

When such an outbreak occurs, food producers are under pressure to find the source of the pathogen as quickly as possible. The technology developed by Pressure BioSciences of South Easton, Mass., is designed to assist with processes like these, and many others. Pressure BioSciences is developing a novel process called Pressure Cycling Technology (PCT) for sample preparation in the study of genomes and proteins. PCT uses hydrostatic pressure (the pressure exerted by a liquid when it is at rest) between ambient and ultra-high levels to release DNA, RNA, or proteins from samples within minutes. Current extraction methods rely on processes such as heat, electrical charge, or sonication, that can alter or even destroy the biomolecules. PCT offers an alternative that has been shown to recover the protein or nucleic acids intact.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 U.S. and 6 foreign patents covering multiple applications of PCT in the life sciences field, including genomic and proteomic sample preparation, pathogen inactivation, the control of chemical (primarily enzymatic) reactions, immunodiagnostics, and protein purification. PBI currently focuses its efforts in the development and sale of PCT-enhanced enzymatic digestion products (instruments and consumables) designed specifically for the mass spectrometry marketplace, as well as sample preparation products for biomarker discovery, soil and plant biology, histology, forensics, and counter-bioterror applications


The entire Sentinel feature is available at  http://www.onemedplace.com/blog/archives/2814

# # #

OneMedPlace is a communications platform for healthcare and life sciences companies to connect with investors, strategic partners, and customers.